ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 711102 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 711102; 2) Community: the network communities that were significantly associated with the response to NSC 711102; 3) Molecule: the relationships between components within communities and NSC 711102; 4) MDR: the compounds that were significantly associated with the NSC 711102.

NSC Compound Enrichment Correlation
NSC 56902 Null 0.0339770934764508 0.17671503
NSC 628561 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-dibutyl- 0.0339770934764508 -0.039799112
NSC 642915 Null 0.0339770934764508 0.11854557
NSC 681644 Camptothecin Derivative 0.0339770934764508 0.15098561
NSC 174121 Methotrexate Derivative 0.0339770934764513 -0.20281442
NSC 39351 Null 0.0339770934764513 -0.23302066
NSC 625497 Antimony, dibromo(4-thiomorpholinecarbodithioato-S,S')-, (T-4)- 0.0339770934764513 -0.22122305
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.0339770934764513 -0.24002589
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.0339770934764513 -0.054347421
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.0339770934764513 -0.039261232
Total:64  Current:40    [First] [Prev] [Next] [Last]